Ito S, Tsuda M, Yoshitake A, Yanai T, Masegi T
Environmental Health Science Laboratory, Sumitomo Chemical Co. Ltd., Osaka, Japan.
Toxicol Pathol. 1998 Mar-Apr;26(2):253-9. doi: 10.1177/019262339802600210.
The effects of in vivo exposure to phenobarbital (PB) on hepatic gap junctional intercellular communication (GJIC) and connexin protein expression in Sprague-Dawley rats were examined by in vivolin vitro dye-transfer assay, immunohistochemical staining, and by Western blot analysis. PB (50 mg/kg) was administered orally once a day for up to 6 wk. The average size of the dye spread after injection of Lucifer Yellow decreased at week 1 and remained at the same level until week 6. The area and number of connexin 32 (Cx32) spots per hepatocyte in the central zone of liver lobules decreased from week 1 to week 6, but no change of Cx32 spots in the peripheral zone was observed. The average area and number of connexin 26 (Cx26) spots per hepatocytes showed no clear change through the experimental periods. The decreased level of Cx32 protein in plasma membranes was observed in the PB group. These results suggest that PB, a liver tumor-promoting agent, inhibits hepatic GJIC in vivo in rats and that aberrant Cx32 protein expression and/or localization may be responsible for this effect.
通过体内-体外染料转移试验、免疫组织化学染色和蛋白质印迹分析,研究了体内暴露于苯巴比妥(PB)对Sprague-Dawley大鼠肝脏间隙连接细胞间通讯(GJIC)和连接蛋白表达的影响。PB(50mg/kg)每天口服给药一次,持续6周。注射荧光素黄后染料扩散的平均大小在第1周时减小,并在第6周前保持在同一水平。肝小叶中央区每个肝细胞中连接蛋白32(Cx32)斑点的面积和数量从第1周至第6周减少,但外周区未观察到Cx32斑点有变化。在整个实验期间,每个肝细胞中连接蛋白26(Cx26)斑点的平均面积和数量未显示出明显变化。在PB组中观察到质膜中Cx32蛋白水平降低。这些结果表明,作为一种肝脏肿瘤促进剂,PB在体内可抑制大鼠肝脏的GJIC,并且Cx32蛋白表达和/或定位异常可能是造成这种效应的原因。